Pillar’s targeted assays help oncologists and researchers identify mutations that drive tumour growth. This knowledge is pivotal in making informed decisions about cancer treatment. By gaining an understanding of the genomic landscape of the tumour, clinicians can tailor treatment options such as targeted therapies and immunotherapies to suit each patient’s needs.
